Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers
Starting today, eligible customers can access a broad assortment of treatment options, including the only FDA-approved GLP-1 weight…
Hims & Hers Opens Up Pre-Launch Waitlist For Ozempic And Wegovy Following Partnership With Novo Nordisk
The company stated that people who sign up for the waitlist will gain priority access to the official…
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock’s Surprise Move
Key Points Hims & Hers’ stock is up after ending its lawsuit with Novo Nordisk. The deal shows…
Novo Nordisk (NVO) Partners With Hims & Hers, Here’s What You Need to Know
Novo Nordisk A/S (NYSE:NVO) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts.…
Novo Nordisk & Hims & Hers: Supply Deal for Ozempic and Wegovy – News and Statistics
Mar 16, 2026 Pharmaceutical firm Novo Nordisk and telehealth provider Hims & Hers Health have entered into a…
Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s
Telehealth company Hims & Hers on Monday announced a “strategic shift” in its business model, partnering with pharmaceutical…
‘They Need Each Other’: Why Hims & Hers and Novo Nordisk Made Up
Lawsuits don’t often end in partnerships. And yet that is the strange but true tale involving Hims &…
Hims & Hers will sell real Ozempic in deal with Novo Nordisk
Hims & Hers and the Danish pharma giant Novo Nordisk have ended a bitter legal feud that will…
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock
BMO Capital maintained its ‘Market Perform’ rating for Novo Nordisk, with a price target of $45, implying an…
Who won the Hims vs. Novo feud?
Novo Nordisk and Hims appear to have buried the hatchet. Hims & Hers is going to sell the…
The era of $199 copycat weight loss drugs is ending — and it could cost patients
Hims & Hers will now sell only the cheaper weight loss drugs at a limited scale, the company…
Hims Novo Nordisk Obesity Drug Deal Recasts Growth And Valuation Story
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…